Condition: Nasopharangeal Cancer · Distant Metastasis · Sponsor: Sun Yat-sen University
This phase III randomized trial evaluates PD-1 inhibitor plus chemotherapy followed by immediate versus salvage locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma. The study aims to evaluate whether salvage locoregional radiotherapy is non-inferior to immediate radiotherapy following PD-1 inhibitor plus GP in de novo metastatic NPC, with potential for reduced toxicity.
This description comes directly from the study's public registry record.
Haiqiang Mai, PhD, MD · +86-020-87343643 · maihq@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| Sun Yat-sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| Hunan Cancer Hospital | Changsha, China | Not Yet Recruiting |
| Fujian Cancer Hospital | Fuzhou, China | Not Yet Recruiting |
| Zhejiang Cancer Hospital | Hangzhou, China | Not Yet Recruiting |
| Guangxi Medical University Cancer Hospital | Nanning, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07235319